Please login to the form below

Not currently logged in
Email:
Password:

Envigo appoints Dr Adrian Hardy as president and CEO

He succeeds Brian Cass in the role

UK research services company Envigo has appointed Dr Adrian Hardy as its new president and chief executive officer, which will take effect from 1 July.

He will succeed Brian Cass in the role who becomes executive chairman, while the previous chairman Andrew Baker becomes chairman emeritus.

Dr Hardy first joined Envigo in 2002 in a business development role, before taking on a series of increasingly senior posts, most recently having served as chief operating officer at the firm.

Prior to joining Envigo, Dr Hardy was a product development manager for Novartis, and served as a director at law firm iPulse.

Dr Hardy said: “I'm delighted and extremely proud to be taking on this role at such an exciting time for Envigo and the research community.

“I've worked closely with Andrew and Brian during my time with the company and would like to thank them for their contributions to making Envigo the world class company it is today.

“Their vision and leadership has positioned our company as a market leader, and I look forward to continuing to work with them in their new roles as we strive to build on the growth and success of Envigo.”

30th June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics